Steven Stein
Technik-/Wissenschafts-/F&E-Leiter bei INCYTE CORPORATION
Vermögen: 5 Mio $ am 30.04.2024
Profil
Steven H. Stein hat die Position des Chief Medical Officer & Executive Vice President bei Incyte Corp. inne. Dr. Stein ist außerdem Mitglied des Vorstands von Kura Oncology, Inc. In seiner früheren Karriere war Dr. Stein Vice President-Global Oncology bei GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs bei Novartis Oncology, Inc. und Senior VP-US Clinical Development & Medical Affair bei Novartis Pharmaceuticals Corp. Dr. Stein erhielt einen Doktortitel von der University of the Witwatersrand.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INCYTE CORPORATION
0,04% | 15.04.2024 | 97 595 ( 0,04% ) | 5 Mio $ | 30.04.2024 |
Aktive Positionen von Steven Stein
| Unternehmen | Position | Beginn |
|---|---|---|
| INCYTE CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 02.03.2015 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Berater | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Steven Stein
| Unternehmen | Position | Ende |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.02.2024 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.02.2015 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.02.2015 |
| GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | 01.04.2011 |
| KURA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Steven Stein
| University of the Witwatersrand | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
